Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Elaine Lam

Concepts (304)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
36
2025
212
7.100
 Why?
Kidney Neoplasms
39
2025
393
6.620
 Why?
Prostatic Neoplasms
13
2023
1044
2.870
 Why?
Neoplasms, Germ Cell and Embryonal
3
2023
78
1.470
 Why?
Antineoplastic Agents
15
2024
2152
1.340
 Why?
Prostate-Specific Antigen
4
2023
165
1.180
 Why?
Antibodies, Monoclonal, Humanized
11
2025
815
1.170
 Why?
Antineoplastic Combined Chemotherapy Protocols
15
2025
1742
1.080
 Why?
Neoplasms
10
2023
2681
0.950
 Why?
Protein Kinase Inhibitors
11
2021
907
0.930
 Why?
Neoplasms, Unknown Primary
1
2025
18
0.930
 Why?
Testicular Neoplasms
3
2023
115
0.920
 Why?
Antineoplastic Agents, Immunological
2
2025
190
0.870
 Why?
Carcinoma, Transitional Cell
4
2025
71
0.820
 Why?
Seminoma
2
2021
20
0.810
 Why?
Carcinoma, Medullary
2
2013
17
0.730
 Why?
Aged
36
2025
24024
0.720
 Why?
Retroperitoneal Neoplasms
1
2021
21
0.700
 Why?
Male
59
2025
68260
0.690
 Why?
Urinary Bladder Neoplasms
4
2025
254
0.680
 Why?
Pneumocystis carinii
1
2020
11
0.650
 Why?
Teratoma
1
2021
118
0.650
 Why?
Spinal Cord Compression
1
2020
21
0.650
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2020
42
0.640
 Why?
Carcinoma, Squamous Cell
1
2025
638
0.640
 Why?
Pneumonia, Pneumocystis
1
2020
35
0.640
 Why?
Humans
86
2025
138651
0.600
 Why?
Euterpe
1
2018
4
0.590
 Why?
Middle Aged
38
2025
33604
0.560
 Why?
Pyrazoles
3
2022
425
0.560
 Why?
TWEAK Receptor
1
2017
5
0.560
 Why?
Prednisone
3
2020
227
0.550
 Why?
Sulfonamides
3
2015
505
0.530
 Why?
Biomarkers, Tumor
6
2025
1224
0.530
 Why?
Abiraterone Acetate
1
2017
15
0.520
 Why?
Aged, 80 and over
17
2025
7677
0.510
 Why?
Adrenal Cortex Hormones
1
2020
496
0.510
 Why?
Plant Extracts
1
2018
207
0.500
 Why?
Pyridines
4
2021
494
0.500
 Why?
Antineoplastic Agents, Hormonal
2
2015
168
0.480
 Why?
Neoplasm Recurrence, Local
3
2023
1057
0.480
 Why?
Neoplasm Metastasis
9
2020
666
0.470
 Why?
Carcinoma, Papillary
1
2015
72
0.460
 Why?
Brain Neoplasms
2
2021
1267
0.450
 Why?
Patient Reported Outcome Measures
4
2025
416
0.440
 Why?
Paclitaxel
3
2022
237
0.430
 Why?
Everolimus
2
2025
110
0.430
 Why?
Prostatic Neoplasms, Castration-Resistant
3
2022
50
0.430
 Why?
Interleukin-2
2
2014
451
0.420
 Why?
Neoplasms, Complex and Mixed
1
2013
8
0.420
 Why?
Antibodies, Monoclonal
2
2017
1436
0.400
 Why?
Urologic Neoplasms
2
2025
30
0.390
 Why?
Treatment Outcome
17
2025
10923
0.380
 Why?
Retrospective Studies
18
2024
15909
0.380
 Why?
Nephrectomy
4
2024
155
0.370
 Why?
Epothilones
1
2011
1
0.360
 Why?
Carcinoma, Non-Small-Cell Lung
3
2025
1111
0.360
 Why?
Basic Helix-Loop-Helix Transcription Factors
3
2024
245
0.360
 Why?
Angiomyolipoma
1
2011
23
0.360
 Why?
Androgen Antagonists
3
2020
93
0.350
 Why?
Multicenter Studies as Topic
1
2012
320
0.340
 Why?
Deoxycytidine
2
2010
192
0.340
 Why?
Anilides
4
2021
70
0.340
 Why?
Adult
27
2025
38201
0.340
 Why?
Lung Neoplasms
4
2025
2527
0.330
 Why?
Benzenesulfonates
1
2010
23
0.330
 Why?
Suramin
1
2010
8
0.330
 Why?
Maximum Tolerated Dose
6
2022
204
0.300
 Why?
Female
34
2025
73763
0.290
 Why?
Radiosurgery
3
2019
389
0.290
 Why?
Immunotherapy
5
2024
634
0.290
 Why?
Indenes
2
2025
6
0.280
 Why?
Fluorouracil
1
2008
204
0.270
 Why?
Disease Progression
3
2021
2749
0.270
 Why?
Bone Neoplasms
2
2023
246
0.270
 Why?
Quinazolines
1
2008
249
0.260
 Why?
Chemotherapy, Adjuvant
3
2013
375
0.260
 Why?
Neoplasm Staging
7
2017
1372
0.260
 Why?
Practice Guidelines as Topic
4
2024
1567
0.250
 Why?
Platinum
2
2024
51
0.250
 Why?
Thyroid Neoplasms
1
2010
324
0.240
 Why?
Drug Administration Schedule
3
2021
768
0.240
 Why?
B7-H1 Antigen
2
2025
216
0.230
 Why?
Prognosis
5
2023
3984
0.230
 Why?
Sulfones
2
2017
110
0.230
 Why?
Microsatellite Instability
1
2025
41
0.230
 Why?
Phenylurea Compounds
4
2016
95
0.230
 Why?
Ipilimumab
2
2021
32
0.210
 Why?
Benzoxazoles
2
2022
19
0.210
 Why?
Melanoma
2
2025
756
0.210
 Why?
Taxoids
2
2017
101
0.210
 Why?
Multiple Sclerosis
2
2019
460
0.190
 Why?
Bevacizumab
2
2020
139
0.190
 Why?
Kaplan-Meier Estimate
5
2024
896
0.190
 Why?
Mastectomy
1
2023
148
0.190
 Why?
Pyrimidines
3
2022
472
0.180
 Why?
Quantitative Trait Loci
1
2024
361
0.180
 Why?
Administration, Oral
4
2024
788
0.180
 Why?
Remission, Spontaneous
1
2021
40
0.180
 Why?
Biliary Tract Neoplasms
1
2021
29
0.170
 Why?
Celecoxib
2
2012
39
0.170
 Why?
Bariatric Surgery
1
2024
217
0.170
 Why?
Neoplasm, Residual
1
2021
130
0.170
 Why?
Carboplatin
1
2021
146
0.170
 Why?
Phosphatidylinositol 3-Kinases
1
2022
368
0.170
 Why?
Quality of Life
2
2025
2954
0.170
 Why?
Syndrome
1
2021
377
0.160
 Why?
Proto-Oncogene Proteins c-akt
1
2022
442
0.160
 Why?
Combined Modality Therapy
4
2019
1235
0.160
 Why?
Genomics
1
2025
796
0.160
 Why?
Azepines
1
2020
97
0.160
 Why?
Thrombosis
1
2023
374
0.150
 Why?
Antiemetics
1
2020
46
0.150
 Why?
Cancer Care Facilities
1
2020
43
0.150
 Why?
TOR Serine-Threonine Kinases
1
2022
415
0.150
 Why?
Homologous Recombination
1
2019
28
0.150
 Why?
Fatal Outcome
1
2020
309
0.150
 Why?
Morpholines
1
2020
124
0.150
 Why?
Anti-Bacterial Agents
2
2020
1818
0.150
 Why?
MAP Kinase Kinase Kinases
1
2019
72
0.150
 Why?
Pharyngitis
1
2019
24
0.150
 Why?
Streptococcus
1
2019
29
0.150
 Why?
Fruit and Vegetable Juices
1
2018
16
0.150
 Why?
Disease-Free Survival
4
2016
704
0.150
 Why?
Feedback
1
2019
174
0.140
 Why?
Drug Hypersensitivity
1
2020
95
0.140
 Why?
Diagnosis, Computer-Assisted
1
2019
87
0.140
 Why?
Mutation
2
2025
3987
0.140
 Why?
Indans
1
2017
12
0.140
 Why?
Neoplastic Cells, Circulating
2
2016
76
0.140
 Why?
Cost-Benefit Analysis
1
2021
608
0.140
 Why?
Interferon beta-1b
1
2017
2
0.140
 Why?
Liver Neoplasms
1
2023
712
0.130
 Why?
Genome-Wide Association Study
1
2024
1374
0.130
 Why?
Niacinamide
3
2016
82
0.130
 Why?
Proton Therapy
1
2017
14
0.130
 Why?
Erythrocytes, Abnormal
1
2016
12
0.130
 Why?
Streptococcal Infections
1
2019
148
0.130
 Why?
DNA Damage
1
2019
422
0.130
 Why?
Polymorphism, Single Nucleotide
1
2024
2113
0.130
 Why?
Multiple Sclerosis, Relapsing-Remitting
1
2017
76
0.120
 Why?
Neoadjuvant Therapy
2
2023
412
0.120
 Why?
Cell Line, Tumor
3
2020
3392
0.120
 Why?
Dose-Response Relationship, Drug
3
2022
2049
0.120
 Why?
Hematologic Diseases
1
2016
66
0.120
 Why?
Oncolytic Virotherapy
1
2015
15
0.120
 Why?
Indazoles
2
2015
67
0.120
 Why?
Autoimmune Diseases
1
2020
454
0.120
 Why?
Problem Solving
1
2017
156
0.120
 Why?
Mammalian orthoreovirus 3
1
2015
37
0.120
 Why?
Genetic Predisposition to Disease
1
2024
2339
0.120
 Why?
Pyrroles
1
2016
209
0.120
 Why?
Fatigue
2
2022
336
0.120
 Why?
Angiopoietin-1
1
2015
11
0.120
 Why?
Angiopoietin-2
1
2015
15
0.120
 Why?
Nanoparticles
1
2021
469
0.110
 Why?
Receptor, IGF Type 1
1
2015
64
0.110
 Why?
Imidazoles
2
2015
239
0.110
 Why?
Kidney Glomerulus
1
2015
119
0.110
 Why?
Radiation Tolerance
1
2015
96
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2015
262
0.110
 Why?
Soft Tissue Neoplasms
1
2015
116
0.110
 Why?
Magnetic Resonance Imaging
2
2021
3637
0.110
 Why?
Severity of Illness Index
2
2019
2851
0.110
 Why?
Prefrontal Cortex
1
2017
306
0.110
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2013
108
0.100
 Why?
Indoles
1
2016
414
0.100
 Why?
Prostatectomy
1
2013
102
0.100
 Why?
Patient Satisfaction
1
2017
688
0.100
 Why?
Glycine
1
2014
174
0.100
 Why?
Cohort Studies
5
2021
5697
0.100
 Why?
Recombinant Fusion Proteins
1
2015
663
0.090
 Why?
Quinolines
1
2013
150
0.090
 Why?
Tubulin Modulators
1
2011
10
0.090
 Why?
Glomerular Filtration Rate
1
2015
741
0.090
 Why?
Emotions
1
2017
568
0.090
 Why?
Metabolic Clearance Rate
1
2011
116
0.090
 Why?
Algorithms
1
2019
1740
0.090
 Why?
Arthralgia
1
2011
54
0.090
 Why?
Breast Neoplasms
1
2023
2212
0.090
 Why?
Clinical Trials as Topic
1
2015
1034
0.080
 Why?
Area Under Curve
1
2011
319
0.080
 Why?
Peripheral Nervous System Diseases
1
2011
130
0.080
 Why?
Diarrhea
1
2011
183
0.080
 Why?
Mechanistic Target of Rapamycin Complex 1
2
2022
129
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2010
33
0.080
 Why?
Molecular Structure
1
2011
500
0.080
 Why?
Survival Rate
3
2020
1935
0.080
 Why?
Biopsy
1
2013
1072
0.080
 Why?
Tomography, X-Ray Computed
3
2022
2698
0.080
 Why?
Decision Making
1
2017
948
0.080
 Why?
Nomograms
1
2010
54
0.080
 Why?
Radiotherapy, Adjuvant
1
2010
215
0.080
 Why?
Immunohistochemistry
1
2013
1731
0.080
 Why?
Drug Synergism
1
2010
368
0.070
 Why?
Capecitabine
1
2008
41
0.070
 Why?
Infusions, Intravenous
1
2010
411
0.070
 Why?
Positron-Emission Tomography
1
2010
304
0.070
 Why?
Proteinuria
1
2008
96
0.070
 Why?
Hypertension, Pregnancy-Induced
1
2008
66
0.070
 Why?
Young Adult
4
2024
13305
0.060
 Why?
Follow-Up Studies
3
2020
5112
0.060
 Why?
Creatinine
1
2008
486
0.060
 Why?
Risk
1
2008
893
0.060
 Why?
Optical Illusions
1
2005
2
0.060
 Why?
Urothelium
1
2025
37
0.060
 Why?
Risk Factors
2
2020
10252
0.060
 Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2024
15
0.050
 Why?
Cytoreduction Surgical Procedures
1
2024
62
0.050
 Why?
Prospective Studies
3
2021
7554
0.050
 Why?
Mastectomy, Segmental
1
2023
97
0.050
 Why?
Adjuvants, Immunologic
1
2024
237
0.050
 Why?
RNA Interference
1
2024
468
0.050
 Why?
Cardiovascular Diseases
1
2014
2053
0.050
 Why?
Disease Management
2
2017
622
0.050
 Why?
RNA, Small Interfering
1
2024
626
0.050
 Why?
Cisplatin
1
2023
327
0.040
 Why?
Nephritis, Interstitial
1
2020
12
0.040
 Why?
Aurora Kinase A
1
2020
55
0.040
 Why?
International Agencies
1
2020
33
0.040
 Why?
Drug Evaluation
1
2020
84
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Lymphocytes
1
2022
395
0.040
 Why?
Nausea
1
2020
111
0.040
 Why?
Hong Kong
1
2019
8
0.040
 Why?
Analysis of Variance
2
2017
1317
0.040
 Why?
Time Factors
1
2010
6851
0.040
 Why?
Medical Oncology
1
2022
304
0.040
 Why?
Vomiting
1
2020
129
0.040
 Why?
Sex Factors
1
2025
2044
0.040
 Why?
Lymphatic Metastasis
1
2020
323
0.040
 Why?
Hospitals
1
2023
695
0.040
 Why?
Central Nervous System
1
2020
263
0.040
 Why?
United States
2
2017
14938
0.030
 Why?
Genetic Testing
1
2020
451
0.030
 Why?
Retreatment
1
2017
73
0.030
 Why?
Databases, Factual
1
2023
1415
0.030
 Why?
Drug Therapy, Combination
1
2020
1032
0.030
 Why?
Xenograft Model Antitumor Assays
1
2020
870
0.030
 Why?
National Cancer Institute (U.S.)
1
2017
48
0.030
 Why?
Receptor Protein-Tyrosine Kinases
1
2019
231
0.030
 Why?
Erythrocyte Indices
1
2016
30
0.030
 Why?
Academic Medical Centers
1
2020
514
0.030
 Why?
Antimicrobial Stewardship
1
2019
119
0.030
 Why?
Anti-Inflammatory Agents
1
2020
476
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2019
253
0.030
 Why?
Clinical Decision-Making
1
2019
334
0.030
 Why?
Case-Control Studies
1
2024
3523
0.030
 Why?
Neutrophils
1
2022
1274
0.030
 Why?
Acute Disease
1
2019
994
0.030
 Why?
Abdominal Neoplasms
1
2015
38
0.030
 Why?
Thoracic Neoplasms
1
2015
37
0.030
 Why?
Tosyl Compounds
1
2015
16
0.030
 Why?
Antibodies, Neoplasm
1
2015
33
0.030
 Why?
Kidney Function Tests
1
2015
156
0.030
 Why?
Reaction Time
1
2017
421
0.030
 Why?
Drug Resistance, Neoplasm
1
2020
801
0.030
 Why?
Craniocerebral Trauma
1
2017
170
0.030
 Why?
Angiogenesis Inhibitors
1
2016
230
0.030
 Why?
Neoplasm Grading
1
2015
305
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2015
138
0.030
 Why?
Organ Size
1
2015
471
0.030
 Why?
Radiotherapy
1
2015
207
0.030
 Why?
Postoperative Period
1
2015
355
0.030
 Why?
Radiotherapy, Intensity-Modulated
1
2015
137
0.030
 Why?
Demography
1
2015
296
0.030
 Why?
Nitriles
1
2015
176
0.030
 Why?
STAT5 Transcription Factor
1
2014
57
0.030
 Why?
Recurrence
1
2017
1084
0.030
 Why?
Drug Interactions
1
2015
404
0.030
 Why?
Gonadotropin-Releasing Hormone
1
2015
212
0.030
 Why?
Medication Adherence
1
2017
504
0.020
 Why?
Longitudinal Studies
1
2020
2844
0.020
 Why?
ErbB Receptors
1
2015
609
0.020
 Why?
Proportional Hazards Models
1
2015
1229
0.020
 Why?
Neuropsychological Tests
1
2017
1058
0.020
 Why?
Cell Survival
1
2015
1123
0.020
 Why?
Double-Blind Method
1
2016
1949
0.020
 Why?
T-Lymphocytes, Regulatory
1
2014
386
0.020
 Why?
Molecular Targeted Therapy
1
2014
413
0.020
 Why?
Biomarkers
1
2022
4092
0.020
 Why?
Proto-Oncogene Proteins
1
2014
620
0.020
 Why?
Enzyme Inhibitors
1
2014
847
0.020
 Why?
Cell Cycle Proteins
1
2014
616
0.020
 Why?
Logistic Models
1
2015
2065
0.020
 Why?
Reagent Strips
1
2008
8
0.020
 Why?
Primary Health Care
1
2019
1777
0.020
 Why?
Urinalysis
1
2008
77
0.020
 Why?
Albuminuria
1
2008
185
0.020
 Why?
Diagnostic Tests, Routine
1
2008
110
0.020
 Why?
Vision, Monocular
1
2005
4
0.010
 Why?
Psychophysics
1
2005
15
0.010
 Why?
Eye Enucleation
1
2005
15
0.010
 Why?
Vision, Binocular
1
2005
41
0.010
 Why?
Adolescent
2
2020
21564
0.010
 Why?
Animals
2
2020
37217
0.010
 Why?
Orientation
1
2005
49
0.010
 Why?
Pattern Recognition, Visual
1
2005
102
0.010
 Why?
Photic Stimulation
1
2005
252
0.010
 Why?
Sensitivity and Specificity
1
2008
1941
0.010
 Why?
Mice
1
2020
17814
0.010
 Why?
Signal Transduction
1
2014
5086
0.010
 Why?
Pregnancy
1
2008
6829
0.010
 Why?
Child
1
2005
21921
0.000
 Why?
Lam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (304) concept(s)
_
Co-Authors Expand Description
See all (50) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)